Latest Period
Q4 2025
Security Snapshot
Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) Institutional Ownership
CUSIP: 08205P209
13F Institutional Holders and Ownership History from Q3 2023 to Q1 2026
Institutions Reporting
71
Shares (Excl. Options)
31,662,101
Price
$13.47
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value $0.0001
- Symbol
- BNTC on Nasdaq
- Shares outstanding
- 35,393,481
- Price per share
- $10.97
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 31,662,101
- Total reported value
- $426,562,132
- % of total 13F portfolios
- 0%
- Share change
- +8,450,248
- Value change
- +$113,780,072
- Number of holders
- 71
- Price from insider filings
- $10.97
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 is tracked under CUSIP 08205P209.
- 71 institutions reported positions in Q4 2025.
- 6 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 71 to 24 between Q4 2025 and Q1 2026.
- Reported value moved from $426,562,132 to $23,185,049.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 71 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 08205P209?
CUSIP 08205P209 identifies BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 08205P209:
Significant Owners of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 44% | -12% | $249,200,088 | +$30,000,153 | 17,761,945 | +14% | SUVRETTA CAPITAL MANAGEMENT, LLC | 07 Nov 2025 |
| FRANKLIN RESOURCES INC | 11% | -29% | $50,561,782 | -$5,287,404 | 3,751,709 | -9.5% | Franklin Resources, Inc. | 31 Dec 2025 |
| JANUS HENDERSON GROUP PLC | 10% | -12% | $44,484,293 | -$292,158,468 | 3,382,836 | -87% | JANUS HENDERSON GROUP PLC | 28 Nov 2025 |
| RA CAPITAL MANAGEMENT, L.P. | 5.5% | $24,327,500 | 1,850,000 | RA Capital Management, L.P. | 07 Nov 2025 | |||
| HBM Healthcare Investments (Cayman) Ltd. | 4.5% | $14,156,282 | 1,041,669 | HBM Healthcare Investments (Cayman) Ltd. | 31 Dec 2024 | |||
| Nantahala Capital Management, LLC | 4.4% | -53% | $14,111,462 | 1,038,371 | 0% | Nantahala Capital Management, LLC | 31 Mar 2025 |
As of 31 Dec 2025, 71 institutional investors reported holding 31,662,101 shares of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC). This represents 89% of the company’s total 35,393,481 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) together control 87% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 33% | 11,548,351 | +17% | 3.9% | $155,556,288 |
| JANUS HENDERSON GROUP PLC | 8.2% | 2,911,688 | 0% | 0.02% | $39,293,230 |
| FRANKLIN RESOURCES INC | 6.2% | 2,197,305 | -15% | 0.01% | $29,597,698 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6% | 2,120,672 | +7.5% | 0.04% | $28,565,452 |
| RA CAPITAL MANAGEMENT, L.P. | 5.2% | 1,850,000 | 0.26% | $24,919,500 | |
| VANGUARD GROUP INC | 3.3% | 1,174,758 | +18% | 0% | $15,823,990 |
| Nantahala Capital Management, LLC | 2.9% | 1,038,371 | +24% | 0.83% | $13,986,857 |
| BlackRock, Inc. | 2.8% | 992,347 | +5% | 0% | $13,366,914 |
| INFINITUM ASSET MANAGEMENT, LLC | 2.5% | 898,871 | +80% | 1.8% | $12,107,792 |
| Siren, L.L.C. | 2.2% | 775,000 | 0.31% | $10,439,250 | |
| Alyeska Investment Group, L.P. | 2.1% | 750,000 | 0.03% | $10,102,500 | |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.1% | 731,717 | +165% | 1.4% | $9,856,228 |
| Balyasny Asset Management L.P. | 1.8% | 651,558 | 0.02% | $8,776,486 | |
| MILLENNIUM MANAGEMENT LLC | 1.7% | 613,160 | 0.01% | $8,259,265 | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3% | 453,375 | +3.4% | 0% | $6,108,556 |
| Longaeva Partners L.P. | 0.82% | 290,000 | +673% | 0.46% | $3,906,300 |
| AWM Investment Company, Inc. | 0.8% | 282,977 | +55% | 0.37% | $3,811,700 |
| AMERIPRISE FINANCIAL INC | 0.79% | 280,727 | +82% | 0% | $3,781,392 |
| Schonfeld Strategic Advisors LLC | 0.74% | 262,205 | +0.69% | 0.02% | $3,531,900 |
| STATE STREET CORP | 0.69% | 245,051 | +12% | 0% | $3,300,837 |
| MYDA Advisors LLC | 0.64% | 225,000 | +221% | 0.85% | $3,030,750 |
| GOLDMAN SACHS GROUP INC | 0.49% | 174,041 | -10% | 0% | $2,344,332 |
| Simplify Asset Management Inc. | 0.43% | 151,163 | +92% | 0.03% | $2,036,166 |
| BURKEHILL GLOBAL MANAGEMENT, LP | 0.42% | 150,000 | 0.13% | $2,020,500 | |
| NORTHERN TRUST CORP | 0.36% | 126,160 | -3.4% | 0% | $1,699,375 |
Institutional Holders of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 2,177,000 | $23,185,049 | +$5,850,145 | $10.65 | 24 |
| 2025 Q4 | 31,662,101 | $426,562,132 | +$113,780,072 | $13.47 | 71 |
| 2025 Q3 | 23,155,291 | $324,725,438 | +$6,865,174 | $14.03 | 55 |
| 2025 Q2 | 22,685,530 | $265,306,276 | +$16,737,178 | $11.70 | 56 |
| 2025 Q1 | 21,243,183 | $277,395,506 | +$28,289,371 | $13.01 | 37 |
| 2024 Q4 | 18,997,897 | $240,166,135 | +$64,576,294 | $12.63 | 30 |
| 2024 Q3 | 13,715,023 | $126,792,177 | +$73,385,856 | $9.19 | 25 |
| 2024 Q2 | 5,729,459 | $39,940,820 | +$31,087,038 | $6.99 | 18 |
| 2024 Q1 | 1,270,837 | $6,576,960 | +$379,920 | $5.25 | 13 |
| 2023 Q4 | 1,197,615 | $3,880,452 | -$214,565 | $3.23 | 13 |
| 2023 Q3 | 1,267,947 | $3,838,114 | +$3,838,114 | $3.02 | 11 |